Solutions Overview

Today’s cancer treatments are varied, complicated and costly. Oncology Analytics provides the critical missing link between health plans and providers: access to current, evidence-based, disease-specific analytics on all cancer types and treatment options.

Solutions that Put Patients First

It has been estimated that oncologists would need 29 hours a day to keep up with the research and findings of new cancer treatments that enter the market each day. Oncology Analytics relieves this burden through a combination of technology-enabled services, supported by our dedicated clinical team of board-certified oncology physicians and pharmacists.

e-Prior Authorization

Oncology Analytics e-Prior Authorization platform is purpose-built for oncology to efficiently evaluate and approve high-quality and high-value treatments for cancer care.
Read More

Specialty Oncology Case Review

For complex and complicated patient cases, the Oncology Analytics’ Clinical Team facilitates peer-to-peer reviews in which the efficacy of the recommended cancer treatment is always prioritized over the cost of therapy.
Read More

Cancer Care Insights & Analytics

Oncology Analytics offers deep insights and analytics for health plans and providers, helping to drive further development and improvement of cancer care.
Read More

e-Prior Authorization

Oncology Analytics e-Prior Authorization platform is purpose-built for oncology to efficiently evaluate and approve high-quality and high-value treatments for cancer care.

Used by physicians to support over 4.3 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform covers the full spectrum of therapeutics, across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy, and supportive care.

Using a simple user interface, physicians enter their treatment recommendation and receive an automatic authorization if their request lies within recognized guidelines.

Treatments requested that are outside of the guidelines receive a further review from the Oncology Analytics Clinical Oncology Team. The Clinical Oncology Team then collaborates with the physicians to ensure that the treatment is optimized to the individual patient. Ninety percent of treatment requests are approved automatically or with limited follow up.

All treatment protocols contained within the e-Prior Authorization platform are reviewed and scored by our Clinical Oncology Team for efficacy, toxicity, and affordability. New indications for treatment approved by the FDA and newly published cancer research are immediately entered into the system.

Oncology Analytics has proven that evidence-based medicine works in the delivery of efficacious and affordable cancer care.

Otis Brawley, MD
Former Chief Medical & Scientific Officer, Executive VP, American Cancer Society

Specialty Oncology Case Review

For complex patient cases, our Clinical Oncology Team facilitates peer-to-peer reviews which may include in-depth reviews by our Distinguished Academic Advisory Board.

Treating oncologists have the opportunity to engage in peer-to-peer discussions of patient cases with Oncology Analytics’ board-certified oncologists, radiation oncologists, hematologists, and pharmacists, to ensure the recommended therapy is the most efficacious, affordable and least toxic and provides the best evidence-based potential outcome.

Specialty Oncology Case Reviews provide a guaranteed “second opinion” for the patient. We recognize that sometimes costly treatments represent the best quality of patient care. However, in many cases there are often less costly and equally efficacious alternatives. In addition, Specialty Oncology Case Reviews can potentially identify additional cancer treatment options, such as clinical trials or compassionate use, which may not be readily apparent.

I am amazed how Oncology Analytics manages difficult cases with varying existing scientific opinions. They have proven to me that they always have the patient’s best interest in mind. I personally would like to thank OA in the name of my patient.

Izidore Lossos, MD
Oncologist, University of Miami Sylvester Cancer Center

Cancer Care Insights & Analytics

Aggregating oncology data from multiple sources is a difficult task for health plans. Gaining immediate, actionable insights from the data is even more challenging.


Oncology Insights is an integrated feature of Oncology Analytics’ standard Utilization Management solution. The analytics leverage a combination of authorization data, claims data, and Oncology Analytics’ comparative benchmarks to help health plans gain deep analytic insights into key business areas such as oncology drug spend, disease assignments, the latest drug trends in their population, and insights into their provider network efficiency.

By using Oncology Insights, health plans get access to a multi-disciplinary advisory team, consisting of board-certified oncology pharmacists and clinical analysts, who help interpret the data and surface immediate actionable insights.

This multi-faceted approach to reporting and analytics lessens health plans’ burden of managing multiple data sources and ensures their focus on strategic areas that will have the greatest impact on their members.


The analytics from Oncology Insights center around 3 key areas: Provider Performance, Drug Spend & Trend, and Oncology Population Management.

Two-thirds of men with low-risk prostate cancer are over-treated. Oncology Analytics uses the latest Epstein criteria to help urologists to decide which early-stage prostate cancer patients may be appropriate candidates for active surveillance rather than surgery or radiotherapy.

Jonathan Epstein, MD
Pathologist, Johns Hopkins Hospital

The Provider Performance Scorecard uses objective criteria to measure how practices and providers are performing across the network, as well as against other providers outside of the network.

The Oncology Population Management module provides insight into the changes in health plan drug expenditure over time.

The Drug Spend & Trend module provides insight into the changes in health plan drug expenditure over time.

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!